Related Experiment Videos
Cytokines and signal transduction
Teru Hideshima1, Klaus Podar, Dharminder Chauhan
1Department of Medical Oncology, Dana-Farber Cancer Institite, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Best Practice & Research. Clinical Haematology
|July 20, 2005
Summary
Targeting growth factors and cytokines in multiple myeloma (MM) is crucial. Inhibiting their signaling pathways in the bone marrow microenvironment offers a promising therapeutic strategy for MM patients.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Multiple myeloma (MM) pathogenesis involves complex interactions within the bone marrow (BM) microenvironment.
- Growth factors and cytokines play a significant role in MM cell proliferation, survival, and migration.
Purpose of the Study:
- To review the role of various cytokines in MM pathogenesis.
- To highlight the therapeutic potential of targeting cytokine signaling pathways in MM.
Main Methods:
- Literature review of studies characterizing growth factor roles in MM.
- Analysis of cytokine involvement in MM cell and BM microenvironment interactions.
Main Results:
- Key cytokines implicated include IL-6, IGF-1, VEGF, TNF-alpha, TGF-beta, SDF-1alpha, IL-21, BSF-3, and FGF.
- These cytokines, secreted by stromal cells, endothelial cells, and osteoclasts, promote MM progression and angiogenesis.
Conclusions:
- Inhibition of cytokine-induced signaling cascades presents a rational therapeutic approach for MM.
- Targeting these pathways offers a novel strategy to improve patient outcomes in multiple myeloma.